VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 100 filers reported holding VERONA PHARMA PLC in Q3 2023. The put-call ratio across all filers is 3.08 and the average weighting 0.6%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bank of New York Mellon Corp | 26,478 | $431,592 | 0.00% |
| ENVESTNET ASSET MANAGEMENT INC | 27,648 | $450,662 | 0.00% |
| Citadel Advisors | 7,900 | $128,770 | 0.00% |
| Citadel Advisors | 39,300 | $640,590 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 38,100 | $621,030 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 10,607 | $172,894 | 0.00% |
| Daiwa Securities Group Inc. | 244 | $4 | 0.00% |
External links
This page lists VERONA PHARMA PLC's shareholders in Q3 2023. To view VERONA PHARMA PLC's shareholder history, click here.